Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Actinic keratoses (AKs) are small scaly red areas of skin characterised histologically by dysplasia, a minority of which are thought to be precursors of squamous cell carcinoma (SCC), and which show a high frequency of regression. Surprisingly, in view of their benign clinical course, they show a high frequency of loss of heterozygosity (LOH) with a median loss of four loci with almost 20% of lesions showing loss of eight or more alleles, as well as frequent
p53
mutation. Loss was common on 3p (31%), 9p (39%), 9q (22%), 13q (52%), 17p (64%) and 17q (46%), and allele loss correlated with dysplasia. Topological disturbance of p21WAF1/
CIP1
expression correlated with allele loss but was also seen together with increased wild-type
p53
expression and an increase in the fraction of cycling cells in the absence of allele loss or
p53
mutation, and is likely to represent an early change. P21WAF1/
CIP1
expression appeared independent of
p53
status. The frequency of LOH in AKs exceeded that of (invasive) SCCs suggesting that the relation between the accumulation of genetic change and behaviour for non-melanoma skin cancer is not straightforward.
...
PMID:Genetic change in actinic keratoses. 870 May 6
Towards dissecting the regulation of terminal differentiation, including growth arrest and apoptosis, myeloid differentiation primary response (MyD) genes, induced in the absence of de novo protein synthesis following induction of M1 myeloblastic leukemia cells for terminal differentiation have been isolated. MyD118 was one of the novel MyD genes cloned, subsequently observed also to be a primary response gene to TGF-beta, which induces M1 cells for growth arrest and apoptosis uncoupled from differentiation. The MyD118 encoded protein was observed to be remarkably similar to the protein encoded by Gadd45, a growth arrest and DNA damage induced gene, regulated in part by the
tumor suppressor p53
. Though evidence has accumulated that MyD118 functions as an important modulator of negative growth control both in hematopoietic and non-hematopoietic cells, its mechanism of action is unknown. To better understand the role(s) of MyD118 in negative growth control, we have analysed the expression and biological characteristics of the MyD118 protein, compared to the Gadd45 protein, in distinct pathways of growth arrest and apoptosis, including
p53
dependent and independent pathways either coupled or uncoupled from differentiation. It is shown that MyD118 and Gadd45 differentially accumulated upon induction of distinct pathways of growth arrest and apoptosis; notably, MyD118, but not Gadd45, was induced by TGF-beta, whereas Gadd45, but not MyD118, was induced by activating wild type (wt)
p53
function. It is also shown that MyD118 is a nuclear protein, which regardless of the pathway induced, predominantly localized within the cell nucleus, and interacted with the DNA replication and repair protein PCNA and the cyclin dependent kinase inhibitor P21WAF1/
CIP1
. MyD118 also modestly stimulated DNA repair in vitro. All of these characteristics were shared with Gadd45. Finally, it is demonstrated that MyD118, Gadd45 and p21 synergized in the suppression of colony formation by NIH3T3 cells. Taken together, these findings demonstrate that MyD118 and Gadd45 are representative of a new protein family that share remarkable functional similarities in the control of distinct pathways of negative growth, including the suppression of cellular growth and programmed cell death.
...
PMID:The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. 870 May 17
p21WAF1/
CIP1
which belongs to a class of regulatory proteins that interact with cyclin dependent kinases is a potent inhibitor of these kinases. The inhibition of the cyclin dependent kinases induces an arrest of cells in the G phase of the cell cycle. In addition p21WAF1/
CIP1
associates with PCNA and inhibits DNA replication. Here, we show that p21WAF1/
CIP1
binds to the regulatory beta-subunit of protein kinase CK2 but not to the catalytic alpha-subunit. Binding of p21WAF1/
CIP1
down regulates the kinase activity of CK2 with respect to the phosphorylation of the beta-subunit of CK2, casein and the C-terminus of
p53
. This study demonstrates a new binding partner for the regulatory beta-subunit of protein kinase CK2 which regulates the activity of the holoenzyme.
...
PMID:p21WAF1/CIP1 interacts with protein kinase CK2. 871 Mar 78
In normal epithelia differentiation and proliferation are regulated by factors involving
p53
and related pathways. WAF1/
CIP1
protein is believed to inhibit cell growth as a downstream mediator of
p53
function. Also, WAF1/
CIP1
is identified as a candidate gene linking differentiation signals to G1 arrest. Different epithelia with different keratinizing profiles respond differently to differentiation/proliferation signals, such as calcium or interferon gamma (IFNgamma). Other factors, such as
p53
mutation or presence of human papillomaviruses (HPVs) also affect responses to those signals. Since WAF1/
CIP1
can be regulated via a
p53
-dependent or an independent manner, our study aimed to determine: a.) differentiation-related expression of WAF1/
CIP1
in keratinocytes, b.) involvement of WAF1/
CIP1
in IFNgamma action, and c.)
p53
-dependence of WAF1/
CIP1
transcription under these conditions. The results demonstrated that differentiation increases WAF1/
CIP1
transcription in keratinizing but not in nonkeratinizing keratinocytes in a
p53
-independent manner. IFNgamma upregulated WAF1/
CIP1
in keratinizing keratinocytes in a differentiation and
p53
dependent manner. Inactivation of wild type
p53
by mutation or by presence of HPVs uncouples IFNgamma-mediated WAF1/
CIP1
transcription from
p53
and from differentiation. Our data suggest a mechanism which operates via WAF1/
CIP1
in keratinocytes and regulates epithelial differentiation/proliferation under different physiological conditions.
...
PMID:Differentiation and IFN gamma regulate WAF1/CIP1 transcription in p53-independent and p53-dependent pathways in epithelial cells. 872 18
Normally growing cells promptly cease DNA synthesis when exposed to genotoxic stresses, such as radiation, and this cell-cycle arrest prevents the accumulation of mutations. The transcription factor interferon regulatory factor (IRF)-1 is essential for the regulation of the interferon system, inhibits cell growth, and manifests tumour-suppressor activities. Here we show that mouse embryonic fibroblasts (EFs) lacking IRF-1 are deficient in their ability to undergo DNA-damage-induced cell-cycle arrest. A similar phenotype has been observed in EFs lacking the tumour suppressor
p53
(refs 8, 9), although the expression of IRF-1 and
p53
are independent of one another. Furthermore, we show that transcriptional induction of the gene encoding p21 (WAF1,
CIP1
), a cell-cycle inhibitor, by gamma-irradiation is dependent on both
p53
and IRF-1, and that the p21 promoter is activated, either directly or indirectly, by both in a transient cotransfection assay. These two tumour-suppressor transcription factors therefore converge functionally to regulate the cell cycle through the activation of a common target gene.
...
PMID:Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. 875 76
Induction of
p53
activity in cells undergoing DNA synthesis represents a molecular conflict that can lead to apoptosis. During angiogenesis, proliferative endothelial cells become apoptotic in response to antagonists of integrin alphavbeta3 and this leads to the regression of angiogenic blood vessels, thereby blocking the growth of various human tumors. Evidence is presented that administration of alphavbeta3 antagonists during angiogenesis in vivo selectively caused activation of endothelial cell
p53
and increased expression of the
p53
-inducible cell cycle inhibitor p21WAF1/
CIP1
. In vitro studies revealed that the ligation state of human endothelial cell alphavbeta3 directly influenced
p53
activity and the bax cell death pathway. Specifically, agonists of endothelial cell alphavbeta3, but not other integrins, suppressed
p53
activity, blocked p21WAF1/
CIP1
expression, and increased the bcl-2/bax ratio, thereby promoting cell survival. Thus, ligation of vascular cell integrin alphavbeta3 promotes a critical and specific adhesion-dependent cell survival signal during angiogenesis leading to inhibition of
p53
activity, decreased expression of p21WAF1/
CIP1
, and suppression of the bax cell death pathway.
...
PMID:Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. 875 53
The combination of the microtubule active drug taxol with radiation has shown promise for use in combined modality therapy. Recent studies have demonstrated that radiation and a wide range of chemotherapy agents, including microtubule active drugs, induce
p53
. In certain circumstances, the induction of
p53
has been shown to be an important parameter in the response of a tumour to cytotoxic treatment. We examined the induction of
p53
and its downstream target, p21WAF1/
CIP1
, by the microtubule active agents taxol and vinblastine with radiation. An increase in induction of both
p53
and p21 WAF1/
CIP1
was demonstrated when radiation was added to either taxol or vinblastine treatment. These results, in conjunction with data on taxol and vinblastine induction of p21WAF1/
CIP1
, suggest a rationale for the combination therapy.
...
PMID:The interaction of taxol and vinblastine with radiation induction of p53 and p21 WAF1/CIP1. 876 53
The DNA-dependent protein kinase (DNA-PK), whose catalytic subunit shows structural similarities to the Ataxia telangiectasia (AT) gene product (ATM), has also been implicated in the
p53
-mediated signal transduction pathway that activates the cellular response to DNA damage produced by ionizing radiation. DNA-PK activity however was not found to be related to the transcriptional induction of WAFl/
CIP1
(p2l) in AT lymphoblastoid cell lines, following treatment with ionizing radiation. Normal protein and transcription levels of Ku70 and Ku80, as well as DNA-PK activity, were found in six different AT cell lines, 1-4 h following exposure to ionizing radiation, timepoints where reduced and delayed transcriptional induction of WAF1/
CIP1
(p21) was observed. WAF1/
CIP1
(p21) was found to be transcriptionally induced by
p53
in normal cell lines over this same time period following exposure to ionizing radiation. These results suggest that despite the findings that in vitro DNA-PK may phosphorylate
p53
, in vivo it would not appear to play a central role in the activation of
p53
as a transcription factor nor can it substitute for the ATM gene product in the cellular response following exposure to ionizing radiation.
...
PMID:The role of Ataxia telangiectasia and the DNA-dependent protein kinase in the p53-mediated cellular response to ionising radiation. 880 86
Induction of apoptosis in tumor cells is an important determinant in the outcome of therapy. Molecular details of the apoptosis pathway, however, are still poorly defined. The recently discovered WAF1/
CIP1
gene is a potent inhibitor of cyclin-dependent kinases and a mediator of tumor-suppressor
p53
-dependent apoptosis by DNA damage. In addition, WAF1/
CIP1
expression is shown to be triggered through the
p53
-independent pathway. The relationship between WAF1/
CIP1
and
p53
-independent apoptosis by DNA damage, however, remains unclear. In this study, we show that WAF1/
CIP1
was induced in
p53
-dependent apoptosis of U87-MG glioma cells by cis-diamminedichloroplatinum (cisplatin), and overexpression of WAF1/
CIP1
induced apoptosis in U87-MG cells without cisplatin treatment. In contrast, the
p53
-independent apoptosis of GB-1 glioma cells by cisplatin did not express WAF1/
CIP1
. Overexpression of WAF1/
CIP1
inhibited DNA synthesis in GB-1 cells, but did not induce apoptosis. Interestingly, WAF1/
CIP1
increased the susceptibility of GB-1 cells to cisplatin-induced apoptosis. These results suggest that overexpression of WAF1/
CIP1
may have potential for the treatment of tumors with non-functional
p53
.
...
PMID:WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. 880 2
The
p53
gene is a recessive oncogene whose loss of function can result in cell transformation. Approximately 25% of human breast cancers contain missense mutations in one
p53
allele, leading to inactivation of the mutated protein. In almost all of these cases, the wild-type allele is also lost. However, it remains uncertain whether mutant p53 acts in a dominant negative fashion over the wild-type protein. Two parameters of
p53
function, transcriptional activation and transcriptional repression, were studied under a variety of experimental conditions within malignant and normal breast epithelial cells. Transient transfection of DNA encoding wild-type
p53
was able to transactivate
p53
-responsive promoters. Wild-type
p53
functioned equally well in malignant cells which harbored an endogenous mutation in
p53
, in malignant cells containing normal
p53
and in normal mammary epithelial cells. Co-transfection of cDNAs encoding mutant p53 proteins were unable to inhibit the ability of wild-type
p53
to transactivate the reporter constructs. Repression of viral promoters by normal
p53 protein
was not inhibited by endogenous or co-transfected mutant p53 -proteins. Finally, the
p53
regulated gene WAF1/
CIP1
/p21 was induced following gamma irradiation in normal mammary cells, containing endogenous wild-type
p53
and in the same cells transfected with mutant p53 genes. From these experiments we conclude that mutant p53 proteins do not inactivate the transactivating (or repressing) function of a co-expressed normal
p53 protein
in these cells implying that complete loss of wild-type
p53
is required to eliminate these functions in breast epithelium.
...
PMID:Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells. 880 6
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>